France stops Valneva's chikungunya vaccine rollout in over 65s after safety issue
France’s national public health agency is suspending immunization of adults 65 years and older with Valneva’s chikungunya vaccine Ixchiq after three patients were hospitalized, including …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.